Dr. Abraham Eskenazi, MD

Dr. Eskenazi practices at Sharp Mesa Vista Hospital in San Diego, California, part of Sharp HealthCare.

Dr. Eskenazi's NPI, 1093774168, was assigned on March 18, 2006. Dr. Eskenazi graduated from Tulane School of Medicine in 1999. Dr. Eskenazi holds California license A76892.

Dr. Eskenazi's primary practice is Sharp Mesa Vista Hospital, at 7850 Vista Hill Avenue, San Diego, CA 92123 in San Diego County. The practice phone is (858) 278-4110.

Dr. Eskenazi's primary practice is Sharp Mesa Vista Hospital in San Diego, California, part of Sharp HealthCare. Dr. Eskenazi is also affiliated with Sharp Memorial Hospital. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Eskenazi to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eskenazi practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Eskenazi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Eskenazi is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Eskenazi's licenses on file in 3 states: California, Florida and Texas.

Dmand AI lists acute gallbladder or bile duct inflammation, acute gastroduodenitis, acute kidney failure, acute skin infection, aneurysm, arthritis, chronic anemia and chronic diabetes among the conditions Dr. Eskenazi treats.

CMS data shows 2,188 Medicare services from Dr. Eskenazi across 8 procedure codes in 2024, for 33 Medicare patients. Medicare paid $172,558 for them. Every service was in an office.

CMS counts 33 Medicare patients who saw Dr. Eskenazi in 2024. The largest group is 65 to 74, with 15 patients. 75% of them have arthritis, and 75% have diabetes. 42% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eskenazi's median patient age at 67, with 52% women.

In 2024, Dr. Eskenazi wrote 858 Medicare Part D claims for 30 patients. 85% of them were for generic drugs. CMS names the drug for 519 of them, across 28 drugs with 11 or more claims each, at $47,906 in total drug cost. In 2023, CMS named 372 claims across 20 drugs.

Dr. Eskenazi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 178 procedures of removal of skin lesions by Dr. Eskenazi, more than 78% of the clinicians it reports for that procedure.

CMS Open Payments shows 9 general payments to Dr. Eskenazi from 2 drug and device companies in 2024. Consulting fees make up the largest share, 55% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $200.

Dr. Eskenazi graduated from Tulane School of Medicine in 1999.

Dr. Eskenazi is in network with 5 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.